Besides, acquired resistance to cytarabine in AML cell lines by long-term drug treatment (Additional file 1: Fig. S4B) resulted in the upregulation of PRLR at surface and total protein expression levels (Fig. 5D). This evidence concerns the gene PRLR and acute myeloid leukemia.